Ultramicronized Palmitoylethanolamide (PEA) treatment in symptomatic patients hospitalized with COVID-19 – Theia Clinical Research – Clinical Research Site in Tempa Bay Area

Skip to content

Toggle menu

Home
Enrolling Studies
For Sponsors
About Us

For more information:

ClinicalTrials.gov

1

Join a Clinical Trial

Research Study:

Ultramicronized Palmitoylethanolamide (PEA) treatment in symptomatic patients hospitalized with COVID-19

Please enter your full legal name

* First Name

* Last Name

* Phone

* E-mail

Zip/Postal Code

Age

Best Contact Method

Best Time to Reach You

Morning (8AM - 11AM)
Lunch Time (11AM - 1PM)
Afternoon (1PM - 5PM)
Evening (After 5PM)

How Did You Hear About Us?

© 2024 Theia Clinical Research - Clinical Research Site in Tempa Bay Area. Proudly powered by Sydney